Kestra Medical Technologies, Ltd. Operating Lease Cost
Kestra Medical Technologies, Ltd. (KMTS) reported Operating Lease Cost of $263.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. operating lease, cost for the quarter ending 2026-07-31 was $263.00K, a 19.00% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating lease, cost for the quarter ending 2026-04-30 was $264.00K, a 32.66% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating lease, cost for the quarter ending 2026-01-31 was $278.00K, a 44.79% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating lease, cost for the quarter ending 2025-10-31 was $222.00K, a 15.63% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating lease, cost for fiscal 2026 was $984.00K, a 29.82% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. operating lease, cost for fiscal 2025 was $758.00K, a 23.51% decline from fiscal 2024.
- Kestra Medical Technologies, Ltd. operating lease, cost for fiscal 2024 was $991.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-07-31 | $263.00K 10-Q · filed 2026-09-14 | $527.00K derived: sum of 2 quarters · filed 2026-09-14 | $805.00K derived: sum of 3 quarters · filed 2026-09-14 | $1.03M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $542.00K derived: sum of 2 quarters · filed 2026-07-14 | $764.00K derived: sum of 3 quarters · filed 2026-07-14 | $984.00K 10-K · filed 2026-07-14 |
| 2026-01-31 | $278.00K 10-Q · filed 2026-03-17 | $500.00K derived: sum of 2 quarters · filed 2026-03-17 | $720.00K 10-Q · filed 2026-03-17 | $920.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $222.00K 10-Q · filed 2025-12-11 | $442.00K 10-Q · filed 2025-12-11 | $642.00K derived: sum of 3 quarters · filed 2026-09-14 | $834.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $221.00K 10-Q · filed 2026-09-14 | $420.00K derived: sum of 2 quarters · filed 2026-09-14 | $612.00K derived: sum of 3 quarters · filed 2026-09-14 | $804.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $199.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $391.00K derived: sum of 2 quarters · filed 2026-07-14 | $583.00K derived: sum of 3 quarters · filed 2026-07-14 | $758.00K 10-K · filed 2026-07-14 |
| 2025-01-31 | $192.00K 10-Q · filed 2026-03-17 | $384.00K derived: sum of 2 quarters · filed 2026-03-17 | $559.00K 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $192.00K 10-Q · filed 2025-12-11 | $366.00K 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $174.00K 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $991.00K 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |